Treace Medical Concepts, Inc. · NASDAQ:TMCI

Treace John T. bought 153,763 Treace Medical Concepts, Inc. shares (Form 4)

Traded May 12 to May 14, 2026 · Filed May 14, 2026

From May 12 to May 14, 2026, Treace John T. (Director, Chief Executive Officer, 10% owner) bought 153,763 Treace Medical Concepts, Inc. shares at an average US$2.44 for US$376K, leaving 7,158,313 shares. Filed May 14, 2026 (Form 4).

Bought
153,763 shares
Price
US$2.44 average (US$2.17 to US$2.62)
Value
US$376K
Holding after
7,158,313 shares
Trading plan
No
Role
Director, Chief Executive Officer, 10% owner

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 12, 2026Common StockBuy43,000US$2.177,047,550Direct
May 13, 2026Common StockBuy49,013US$2.467,096,563Direct
May 14, 2026Common StockBuy61,750US$2.627,158,313Direct

Source

View original at SEC

Related